Rv1979c Family assigned · medium auto-curated

H37Rv Rv1979c · MTBC0 mtbc0_002101 · 481 aa · 2245332–2246777 MTBC0 (-) · RefSeq NP_216495.2

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)permease
MTBC0 PGAP re-annotationAPC family permease
Revised (this work)APC family permease. Pfam: AA_permease_2 (PF13520.13), AA_permease (PF00324.28).
Functional category (TubercuList)cell wall and cell processes

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 30 publications

30 TB publications mention this gene. 30 publications discuss this gene. Queried separately, 30 records carry a M. tuberculosis context and none a non-TB mycobacterial context. The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 30: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Comparative in vitro antimicrobial susceptibility profiles of clofazimine and pyrifazimine against clinical isolates of Mycobacterium tuberculosis in southwest China. doi:10.1128/spectrum.02664-25 2026
Phenotypic drug susceptibility testing and genotypic characterization of Bedaquiline resistance in drug resistant Mycobacteriumtuberculosis. doi:10.1016/j.ijmmb.2026.101163 2026
Bedaquiline resistance-associated genetic mutations and minimum inhibitory concentrations in drug-resistant tuberculosis clinical isolates from Limpopo province, South Africa. doi:10.3389/fmicb.2026.1803115 2026
Examination of Genetic Mutations of Clofazimine Resistance in Drug-Resistant Mycobacterium TB Isolates. doi:10.1007/s00284-025-04582-7 2025
In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis. doi:10.1093/jac/dkae405 2025
31 records returned by the alias sweep (a separate sweep from the 30 above; both are shown, neither is exhaustive)

Searched as: Rv1979c, Mb2001c, ML1974 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
No phenotypic resistance observed for most group-3 and -4 variants in Mycobacterium tuberculosis genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context. doi:10.1128/spectrum.02005-26 Microbiol Spectr 2026
Comparative in vitro antimicrobial susceptibility profiles of clofazimine and pyrifazimine against clinical isolates of Mycobacterium tuberculosis in southwest China. doi:10.1128/spectrum.02664-25 Microbiol Spectr 2026
Phenotypic drug susceptibility testing and genotypic characterization of Bedaquiline resistance in drug resistant Mycobacteriumtuberculosis. doi:10.1016/j.ijmmb.2026.101163 Indian J Med Microbiol 2026
Bedaquiline resistance-associated genetic mutations and minimum inhibitory concentrations in drug-resistant tuberculosis clinical isolates from Limpopo province, South Africa. doi:10.3389/fmicb.2026.1803115 Front Microbiol 2026
Examination of Genetic Mutations of Clofazimine Resistance in Drug-Resistant Mycobacterium TB Isolates. doi:10.1007/s00284-025-04582-7 Curr Microbiol 2025
In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis. doi:10.1093/jac/dkae405 J Antimicrob Chemother 2025
Analysis of genetic characteristics associated with reduced bedaquiline susceptibility in multidrug-resistant Mycobacterium tuberculosis. doi:10.1016/j.tube.2024.102572 Tuberculosis (Edinb) 2024
Mutations in Rv0678, Rv2535c, and Rv1979c Confer Resistance to Bedaquiline in Clinical Isolates of Mycobacterium Tuberculosis. doi:10.2174/0118761429314641240815080447 names it Curr Mol Pharmacol 2024
Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis. doi:10.3389/fmed.2023.1304857 Front Med (Lausanne) 2023
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study. doi:10.1016/S2666-5247(23)00172-6 Lancet Microbe 2023
Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China. doi:10.2147/IDR.S429003 Infect Drug Resist 2023
A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant. doi:10.1371/journal.pone.0287019 PLoS One 2023
Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment. doi:10.2147/IDR.S408976 Infect Drug Resist 2023
Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis. doi:10.1016/j.jgar.2023.05.001 J Glob Antimicrob Resist 2023
Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients. doi:10.1016/j.jgar.2023.04.003 J Glob Antimicrob Resist 2023
High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates. doi:10.1080/22221751.2022.2099304 Emerg Microbes Infect 2022
Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates. doi:10.3390/jcm11071927 J Clin Med 2022
Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan. doi:10.1186/s12866-022-02475-4 BMC Microbiol 2022
Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis. doi:10.1016/s2666-5247(21)00175-0 Lancet Microbe 2021
Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis. doi:10.1016/S2666-5247(20)30031-8 Lancet Microbe 2020
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid. doi:10.1093/jac/dkaa136 J Antimicrob Chemother 2020
Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex. doi:10.1186/s13073-020-00726-5 Genome Med 2020
Molecular epidemiology and whole genome sequencing analysis of clinical Mycobacterium bovis from Ghana. doi:10.1371/journal.pone.0209395 PLoS One 2019
Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis. doi:10.1016/j.dib.2018.09.057 Data Brief 2018
In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants. doi:10.1016/j.mimet.2018.08.011 J Microbiol Methods 2018
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region. doi:10.1093/jac/dkx094 J Antimicrob Chemother 2017
Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis. doi:10.1128/AAC.00239-17 Antimicrob Agents Chemother 2017
Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis. doi:10.1093/jac/dkv150 J Antimicrob Chemother 2015
Divergence of immunologic and protective responses of different BCG strains in a murine model. doi:10.1016/j.vaccine.2010.12.012 Vaccine 2011
Region of difference 2 contributes to virulence of Mycobacterium tuberculosis. doi:10.1128/IAI.00824-10 Infect Immun 2011
Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. doi:10.1128/IAI.70.12.6996-7003.2002 Infect Immun 2002

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) antiparallel · 3 % of gene

NeighbourRv1978 (Rv1978, + strand)
Overlap38 bp, 3 % of this gene's length

antiparallel overlap: this gene may inherit essentiality/conservation signal from its neighbour through shared TA sites or promoter constraint, without any protein of its own being produced (cf. Rv2438A/nadE) Signals attributed to this gene (Tn-seq essentiality via shared TA sites, conservation via promoter constraint) should be cross-checked against the neighbour before being read as its own. P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index 1.23 (95% CI -0.30 to 3.68). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.299 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=24 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionUnknown; possibly involved in transport of amino acid across the membrane.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb2001c · 99.6% identity
M. leprae ML1974 · 77.1% identity
M. orygis RJtmp_002041 · 99.6% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WQM5 SwissProt · reviewed · Evidence at protein level
UniProt nameUncharacterized transporter Rv1979c
Curated functionProbable amino-acid or metabolite transport protein.

As checked on 2026-09-23, UniProt listed this protein as Uncharacterized transporter Rv1979c; the revised annotation above goes beyond that record. UniProt may have been recurated since: check the live entry.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category E Amino acid transport and metabolism
eggNOG descriptionAmino acid permease
Orthologous groupCOG0531

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 1.619 · diversifying/relaxed
Polymorphic sites (≥ 0.1% of strains) 2 synonymous, 9 missense, 0 nonsense, 2 frameshift
Disruption 2 distinct premature-stop/frameshift site(s); most common in 0.14% of strains (200) · clonal
Which clade carries which site (attribution) aucun site fixé dans un clade; union over all sites: 357 strains (the count above is a maximum over sites, not a union).
  • NC_000962.3:2222111:G:GA · frameshift · 200 strains — not fixed in any clade
  • NC_000962.3:2222731:TA:T · frameshift · 157 strains — not fixed in any clade
Which clade carries which disrupting site — the question the count above never asked. `disrupt_strains` is a MAXIMUM over sites, not a union: two sites carried by two disjoint clades do not add up there. `disrupt_mode` is derived from the NUMBER of sites alone (convergent at 4 or more), so it says nothing about who carries them. Read this field instead for any evolutionary claim, and mind the distinction it enforces: several clades at the SAME site is shared ancestry, not convergence — convergence requires DIFFERENT sites in DIFFERENT clades. SECOND CORRECTION (P44.8, same day): a clade name listed here is the ROOT of the fine clade that fixes the site, not the whole lineage. Across the 789 fixed sites of this atlas, the fixing sub-clades cover a median of 9.2% of the lineage named, and under 10% for half of them — so read the sub-clade sizes given here, never the lineage name alone.

Read the disruption percentage against its ceiling, not against 100%. The strain collection is deeply imbalanced by clade, so a loss fixed in an entire lineage still shows a small overall fraction: a gene disrupted in every L6 strain caps at 0.96% of the collection, in every M. caprae strain at 0.20%, in every M. microti strain at 0.02%. Of the 705 clades in this collection, 689 have a ceiling below 1%. A figure of "0.15% of strains" is therefore uninterpretable on its own — it can be noise or a complete, lineage-defining loss. Use the clade attribution row above, which gives the sub-clade sizes, and never read the percentage alone.

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Mycobacterium

M. canettii dN/dS (deep-divergence selection) undefined (dS = 0) (low power) · 2 consensus substitution(s)
low power (2 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 17/53 (32%) · mean identity 74.4% · 4/4 closest MTBAP relatives
present in a subset of the genus (17/53 NTM; in 4 of the 4 closest MTBAP relatives) — partial/intermediate conservation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria

present across the genus Mycobacterium (NTM) but not detected in any non-Mycobacterium genome — a Mycobacterium-genus gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Regions of Difference (lineage deletions)

RDGene overlapDeleted in lineages
RD713 100% L5
RD2seal 81% L5

This locus overlaps a Region of Difference — a large deletion that is absent in the listed lineages (from the consolidated MTBC RD analysis over ~145 000 strains; H37Rv coordinates). The gene-overlap column is the fraction of the gene inside the RD. RD deletions are classic lineage markers (e.g. RD9 absent in the animal / M. africanum lineages); a gene deleted in a whole lineage is dispensable there. Lineages tagged n=…, not statistical are the rarest MTBC ecotypes (e.g. the chimpanzee bacillus, M. mungi, M. suricattae), where only a handful of strains have ever been sequenced: the figure is a single-sample observation, not a population frequency, and is shown rather than silently dropped because for these lineages every sequenced strain is itself informative.

Essentiality (transposon mutagenesis)

DeJesus 2017 callGA · growth-advantage
What the call meansgrowth-advantage: insertions enriched
TA sites (Himar1) 39 in the ORF — 0 in the essential state, 0 growth-defect, 18 non-essential, 21 growth-advantage. Saturation 1.000, mean read count 193.692307692. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
38 of these 39 sites are exclusively this ORF's; Measured, not hypothetical: 1 of this ORF's 39 TA sites lies inside Rv1978 (1 site), leaving 38 sites that are exclusively its own. A transposon insertion cannot be assigned to one reading frame rather than the other, so the essentiality call rests on those 38 exclusive sites.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Proteomics (mass spectrometry) detected

MS detectiondetected in 1 of 16 independent MS datasets
Integrated abundance1.17 ppm · rank 3252/3519 (7.6th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox)

Predictionpredicted membrane protein (12 TM helixes)
DeepTMHMM classTM
TM helices (DeepTMHMM)12

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length481 aa
Molecular weight51.1 kDa
Theoretical pI10.05
GRAVY0.813 (hydrophobic)
Aliphatic index118.3
Aromaticity0.114
Instability index19.7 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
AA_permease_2PF13520.13 9.4e-3914–424 Amino acid permease
AA_permeasePF00324.28 3.3e-2919–461 Amino acid permease

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 86.4, confident), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 86.4

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
9h76-assembly1_A 1.00 0.82 0.74 0.82 21% 95% / 100% 2.3e-15 sig 9h76-assembly1_A Bacterial LAT transporter BASC in complex with L-Ala and NB53
8wny-assembly1_B 1.00 0.79 0.75 0.79 19% 96% / 96% 6.1e-15 sig 8wny-assembly1_B Cryo EM map of SLC7A10-SLC3A2 complex in the D-serine bound state
5oqt-assembly1_A 1.00 0.77 0.73 0.77 21% 96% / 94% 2.9e-14 sig 5oqt-assembly1_A Crystal structure of a bacterial cationic amino acid transporter (CAT) homologue
6f34-assembly1_A 1.00 0.75 0.72 0.75 20% 96% / 94% 4.9e-14 sig 6f34-assembly1_A Crystal structure of a bacterial cationic amino acid transporter (CAT) homologue bound to Arginine.
7o82-assembly1_B 1.00 0.78 0.71 0.78 21% 95% / 97% 1.0e-13 sig 7o82-assembly1_B The L-arginine/agmatine antiporter from E. coli at 1.7 A resolution

Foldseek search of the AlphaFold DB model (mean pLDDT 86.4, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)Rv1978 (+ strand, -38 bp gap)
Downstream (3' on genome)mpt64 (- strand, 178 bp gap)

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2031) exponential phase: operon of 5, Rv1979c · Rv1980c · Rv1981c · Rv1982A · Rv1982c (coverage 583.64)
not expressed (stationary phase) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) trcR (activates)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: mpt64 (immunogenic protein Mpt64), medium confidence (score 569, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 38 partners at medium confidence (7 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 38 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv2471 aglA exp (transferred) curated alpha-glucosidase AglA 777 766 experimental:451 database:577
Rv0126 treS exp (transferred) curated trehalose synthase/amylase TreS 777 766 experimental:451 database:577
Rv1327c glgE exp (transferred) curated alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase 775 764 experimental:451 database:577
Rv1980c mpt64 immunogenic protein Mpt64 735 569 ctx neighborhood:475 textmining:411
Rv0178 Mce associated membrane protein 459 438
Rv3492c Mce associated protein 446 425
Rv1334 mec [CysO 418 419
Rv1363c membrane protein 438 417
Rv0200 transmembrane protein 436 414
Rv1362c membrane protein 436 414
Rv1973 Mce associated membrane protein 435 414
Rv1972 Mce associated membrane protein 435 414
Rv2390c hypothetical protein 435 414
Rv0199 membrane protein 435 414
Rv0177 Mce associated protein 432 411

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: permease
  • MTBC0 PGAP product: APC family permease
  • Pfam (hmmscan --cut_ga): AA_permease_2 PF13520.13 (E=9e-39), AA_permease PF00324.28 (E=3e-29)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216495.2)
  • Domains: Pfam-A via hmmscan --cut_ga — AA_permease_2 (PF13520.13), AA_permease (PF00324.28)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0531
  • Curated reference: UniProt P9WQM5 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 86.4)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 38 functional partner(s); context anchor mpt64
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Regions of Difference: consolidated MTBC RD analysis (H37Rv coordinates); RD framework from Brosch et al. 2002 (doi:10.1073/pnas.052548299) and Gagneux & Small 2007 (doi:10.1016/S1473-3099(07)70108-1)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_002101|Rv1979c|
MVGPRTRGYAIHKLGFCSVVMLGINSIIGAGIFLTPGEVIGLAGPFAPMAYVLAGIFAGVVAIVFATAARYVRTNGASYAYTTAAFGRRIGIYVGVTHAITASIAWGVLASFFVSTLLRVAFPDKAWADAEQLFSVKTLTFLGFIGVLLAINLFGNRAIKWANGTSTVGKAFALSAFIVGGLWIITTQHVNNYATAWSAYSATPYSLLGVAEIGKGTFSSMALATIVALYAFTGFESIANAAEEMDAPDRNLPRAIPIAIFSVGAIYLLTLTVAMLLGSNKIAASGDTVKLAAAIGNATFRTIIVVGALISMFGINVAASFGAPRLWTALADSGVLPTRLSRKNQYDVPMVSFAITASLALAFPLALRFDNLHLTGLAVIARFVQFIIVPIALIALARSQAVEHAAVRRNAFTDKVLPLVAIVVSVGLAVSYDYRCIFLVRGGPNYFSIALIVITFIVVPAMAYLHYYRIIRRVGDRPSTR